Unknown

Dataset Information

0

Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients.

ABSTRACT:

SUBMITTER: Happel CS 

PROVIDER: S-EPMC4899149 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients.

Happel Corinne S CS   Stone Kelly D KD   Freeman Alexandra F AF   Shah Nirali N NN   Wang Angela A   Lyons Jonathan J JJ   Guerrerio Pamela A PA   Hickstein Dennis D DD   Su Helen C HC  

The Journal of allergy and clinical immunology 20160128 6

Similar Datasets

Unknown Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency.
| S-EPMC5354354 | biostudies-literature
Unknown Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.
| S-EPMC5757872 | biostudies-literature
Unknown Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
| S-EPMC4989381 | biostudies-literature
Unknown Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation.
| S-EPMC6125184 | biostudies-literature
Unknown Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency.
| S-EPMC2998541 | biostudies-literature
Unknown Selected memory T cells infused post-haploidentical hematopoietic stem cell transplantation persist and hyperexpand.
| S-EPMC10362279 | biostudies-literature
Unknown Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML.
| S-EPMC9851264 | biostudies-literature
Unknown Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
| S-EPMC5846574 | biostudies-literature
Unknown Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation.
| S-EPMC4722698 | biostudies-literature
Unknown Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.
| S-EPMC5682215 | biostudies-literature